Interventional treatment in elderly patients with severe aortic valve stenosis and coronary artery disease
DOI:
https://doi.org/10.52692/1857-0011.2024.1-78.06Keywords:
aortic stenosis, transcatheter aortic valve implantation, coronary artery diseaseAbstract
Background. Aortic stenosis (AS) is a valvular heart disease commonly found in the elderly patients and frequently is associated with coronary artery disease (CAD). The impact of CAD severity and of the percutaneous coronary intervention (PCI) on post-TAVI outcomes is frequently debated. Purpose. Comparison of clinical and hemodynamic outcomes, as well as the rate of major adverse cardiovascular and cerebrovascular events (MACE) in patients undergoing TAVI with PCI (patients with AS and CAD) versus isolated TAVI (patients with AS). Material and methods. Our team conducted a prospective study that included 41 patients, with an age greater than 70 years old, who were diagnosed with severe aortic valve stenosis. After performing coronary angiography, the patients were divided into two groups: 32 patients without significant coronary lesions and 9 patients with multivessel lesions with a Syntax Score <22 and who subsequently underwent coronary angioplasty (PCI). Results. The TAVI procedure was performed with a 100% success rate. After the procedure, the ejection fraction increased inconsiderably in all patients, but the average pressure gradient decreased impressively, the average value being12.59 ± 5.62 mmHg vs 14.78 ± 8.73 mmHg, p< 0.001. The peak velocity of the jet through the aortic valve is 2.36 ± 0.50 m/s vs 2.53 ± 0.83 m/s, p< 0.001.Conclusion. The one-year post-procedural follow-up showed that both groups of patients had a similar rate of MACE, with a significant improvement in clinical-hemodynamic parameters according to transthoracic echocardiography data.
References
Donato M, Ferri N, Lupo MG, Faggin E, Rattazzi M. Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis. Int. J. Mol. Sci. 2020, 21(21), 8263;
Robert O. Bonow, Catherine M. Otto. Valvular Heart Disease: A Companion to Braunwald’s Heart Disease, Fourth edition. Philadelphia, PA :Elsevier/Saunders, 2014
Muhammad Sabbah, et. al. Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation –the third nordic aortic valve intervention trial – NOTION-3, American Heart Journal,Volume 255, 2023, Pages 39-51, ISSN 0002-8703.
Roberta Ancona, Salvatore Comenale Pinto. Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS/AI similar in different parts of the world?. E-Journal of Cardiology Practice, Volume 18, Issue 10, 12 February 2020.
Matta, A. G., et al. (2021). Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation. Journal of interventional cardiology, 2021, 6672400.
Marin, F., Scarsini, R., Kotronias, R. A., et al. (2021). AorticValve Diseaseand Associated Complex CAD: The Interventional Approach. Journal of clinical medicine, 10(5), 946.
Sabbah M, Engstrøm T, De Backer O, Søndergaard L, Lønborg J. Coronary Assessmentand Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge. Front Cardiovasc Med. 2021 May 21;8:654892.
Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-artreview. J Am Coll Cardiol. 2019; 74:362–72.
Michail M, Davies JE, Cameron JD, et al. Pathophysiological coronary and microcirculatory flow alterations in aortic stenosis. Nat Rev Cardiol 2018;15:420–31.
Millan-Iturbe O, Sawaya FJ, Lønborg J, et al. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: real-world results from the East Denmark Heart Registry. Catheter Cardiovasc Interv. 2018; 92:818–26.
Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017; 10:1428–35.
E. Apetrei. Cardiologie clinică. București. Editura Medicală Callisto, 2015.ISBN-13:978-606-8043-18-0
Alain Cribier et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis; First Human Case Description. 25 Nov 2002, 2002;106:3006–3008. doi.org/10.1161/01.CIR.0000047200.36165.B8
Abras M. et. al. Transcatheter aortic valve implantation. First experience of minimally invasive treatment in the Republic of Moldova. Mold Med J. 2020;63(3):58-65. doi: 10.5281/zenodo.3958567.
Abraş, Marcel, et al. Implantarea valvei aortice transcateter cu proteză autoexpandabilă în Republica Moldova. Rezultatele unui an de evidență a primilor zece pacienți. Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 72.1 (2022): 18-22.
Catherine M. Otto et al., 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. In: Circulation. 2021;143:e72–e227
Chen H.Y., Dufresne L., et al. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records. JAMA Cardiol. 2018;3:18–23.
Carmona, A., et al. Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve Replacement. J. Clin. Med. 2020, 9, 2267.
Mourino-Alvarez L, Corbacho-Alonso N, et al. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients. International Journal of Molecular Sciences. 2021; 22(12):6212.
D’Ascenzo F, Verardi R, Visconti M et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14:e1169–77.
Sankaramangalam K, Banerjee K, Kandregula K et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc. 2017;6:e006092.
Martin B. Leon, M.D., Craig R. Smith, M.D., et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016;374:1609-20
Shu-I Lin, Mizuki Miura, Ana Paula Tagliari, Ying- Hsiang Lee, et al. Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation, Interventional Cardiology Review 2020;15:e11.
Karyofillis P, Kostopoulou A, Thomopoulou S, et al. Conduction abnormalities after transcatheter aortic valve implantation. J Geriatr Cardiol 2018;15:105–112.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321–1331.
Siontis GC, J–ni P, Pilgrim T et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta- analysis. J Am CollCardiol. 2014;64:129–40.
Kim WK, Schafer U, Tchetche D, Nef H, Arnold M, Avanzas P, et al. Incidence and outcome of periprocedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration). EurHeart J. (2019) 40:3156–65.
Philippe Généreux, Nicolo Piazza, Maria C. Alu, Tamim Nazif., et al. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. 2021 Jun, 77 (21) 2717–2746.
Tuttle MK, Kiaii B, Van Mieghem NM, et al. Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial. JACC Cardiovasc Interv 2022;15:728-38.
Quynh Nguyen, Jessica GY Luc, Thomas E MacGillivray, Ourania A Preventza, Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-risk Patients with Severe Aortic Stenosis, US Cardiology Review 2022;16:e18.
Eggebrecht H, Mehta RH (2019) Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly. EuroIntervention 14:e1549–e1552
Connie W. Tsao, et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation. 2022;145:e153–e639
Downloads
Published
License
Copyright (c) 2024 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
